Instruction for use: Vero-Atenolol

Trade name of the drug – Vero-Atenolol

Dosage Form: tablets

Active substance: Atenololum

ATX

C07AB03 Atenolol

Pharmacotherapeutic group: Beta-blockers

The nosological classification (ICD-10)

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I20.9 Angina pectoris, unspecified: Angina Syndrome X; Pain in angina; heberden disease; Relief of angina attacks; postinfarction angina; Predinfarktnoe state; Predinfarktny syndrome; The attack of angina pectoris; stenokardicheskie state; Angina with a normal blood pressure; Transient ischemic heart attacks

I49.9 Irregular heartbeat, unspecified: Paroxysmal supraventricular tachycardia; extrasystole arrhythmia; Atrial fibrillation tachysystolic; supraventricular tachyarrhythmia; supraventricular arrhythmias; AV reciprocating tachycardia; AV-nodal reciprocating tachycardia; ventricular fibrillation; Irregular heartbeat; Antidromic reciprocating tachycardia; Cardiac arrhythmias; Arrhythmias; Arrhythmia; Heart arythmy; Arrhythmia due to hypokalemia; ventricular tachyarrhythmias; The high frequency of ventricular contraction; Cardiac arrhythmias; Paroxysmal supraventricular arrhythmia; Paroxysmal supraventricular arrhythmia; Paroxysmal dysrhythmia; Paroxysmal atrial-ventricular rhythm; cardiac arrhythmias; supraventricular tachycardia; tachyarrhythmia; Precordial abnormal pulsation

Composition (per tablet): 1 atenolol tablet contains 0.05 g or 0.1; in blisters of 10 pcs., in a cardboard bundle 5, and 3 packs, respectively.

Pharmacological Properties of Vero-Atenolol

Pharmachologic effect - hypotensive.

Selectively blocking beta1-adrenergic receptors.

Indications for Vero-Atenolol

Arterial hypertension, ischemic heart disease, tachyarrhythmia.

Contraindications for Vero-Atenolol

Hypersensitivity, AV block II-III degree, sick sinus syndrome, sinoatrial block, shock, congestive heart failure, bradycardia (heart rate less than 50 bpm. / Min), hypotension, acidosis, breast-feeding.

Pregnancy and breast-feeding

Be wary of pregnancy. At the time of treatment should stop breastfeeding.

Side effect of Vero-Atenolol

From the nervous system and sensory organs: weakness, dizziness, headache, sleep disturbance.

Cardio-vascular system and blood (blood, hemostasis): AV conduction disorders, circulatory failure, bradycardia, disturbance of peripheral circulation (exacerbation of intermittent claudication and Raynaud's syndrome).

For the skin: sweating, redness, itching, increased symptoms of psoriasis.

Other: dyspeptic disorders, dysfunction of the lacrimal glands, muscle spasms.

Interaction

It enhances the effect of others. Antihypertensives, the negative chronotropic effect of reserpine, metildofy, clonidine, guanfatsina.

Dosage and Administration

Inside, after food, with hypertension and arrhythmias - 0.05 - 0.1 g / day in 1 reception in angina - 0.1 g / day in 1-2 reception, in violation of renal function, the dose is adjusted.

Precautionary measures

Be wary appoint patients with obliterative peripheral arterial disease, Raynaud's syndrome, diabetes mellitus (masking the symptoms of hypoglycemia), chronic obstructive pulmonary disease. In the treatment of ischemic heart disease the drug should be withdrawn gradually (possibly increasing stenokardicheskie pain, myocardial infarction and arrhythmias).

Storage conditions of Vero-Atenolol

In the dark and dry place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use beyond the expiration date printed on the package.